Lenacapavir 300 mg, 463.5 mg/1.5 mL Suppliers & Bulk Manufacturers

Available Forms: Tablet / Injection

Available Strengths: 300 mg, 463.5 mg/1.5 mL

Reference Brands: Yeztugo (USA), Sunlenca (USA)

Category: Anti Viral

Lenacapavir is a Anti Viral product available as Tablet / Injection in strengths 300 mg, 463.5 mg/1.5 mL. It corresponds to the reference brands Yeztugo (USA), Sunlenca (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Lenacapavir is a long-acting antiretroviral medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection, particularly in heavily treatment-experienced patients with multidrug-resistant virus where existing therapies are no longer effective or tolerated. It belongs to a novel class of medicines known as HIV-1 capsid inhibitors and works by targeting the viral capsid protein, disrupting multiple stages of the viral life cycle including assembly, transport, and replication. This unique mechanism makes it effective against strains resistant to other antiretroviral classes.

Lenacapavir is used in combination with other antiretroviral agents as part of an optimized background regimen. One of its key advantages is its long-acting profile, allowing extended dosing intervals that can improve adherence and treatment continuity. Clinical studies have shown strong antiviral activity, sustained viral load reduction, and a manageable safety profile in patients with limited treatment options. It is marketed under the brand name Sunlenca and developed by Gilead Sciences. Ongoing research is also exploring its role in long-acting preventive strategies and combination regimens for durable HIV management.